| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56b82efc3f11d407d80be01b6fc6a716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95c6b16139166429976e9b6e82075e59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15443fa18735dcde4c6fa418659e6c85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c495086543e37e253bb483b86b297c13 |
| publicationDate |
2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201840583-A |
| titleOfInvention |
Neuroprotective effect of antibodies specific for the protofibril form of beta-beta peptides |
| abstract |
The present invention relates to antibodies specific for the primary fibril form of Aβ peptides, which are used to prevent and / or treat neurodegenerative diseases involving Aβ peptide aggregation, and in particular to prevent Alzheimer's disease and / or Treatment of early symptomatic Alzheimer's disease. The antibody can therefore be used before memory loss and impaired cognitive function, or early in the disease. The antibody even has neurocyte protection against neurotoxicity caused by Aβ peptides. |
| priorityDate |
2017-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |